[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 2512 Reported in Senate (RS)]

<DOC>





                                                       Calendar No. 389
114th CONGRESS
  2d Session
                                S. 2512

To expand the tropical disease product priority review voucher program 
                to encourage treatments for Zika virus.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            February 8, 2016

   Mr. Franken (for himself, Mr. Nelson, Mr. Isakson, Mr. Brown, Mr. 
Menendez, Mr. Kirk, Mr. Casey, Mr. Portman, Mr. Murphy, Ms. Klobuchar, 
 Mrs. Murray, and Mr. Alexander) introduced the following bill; which 
  was read twice and referred to the Committee on Health, Education, 
                          Labor, and Pensions

                             March 15, 2016

              Reported by Mr. Alexander, with an amendment
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]

_______________________________________________________________________

                                 A BILL


 
To expand the tropical disease product priority review voucher program 
                to encourage treatments for Zika virus.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

<DELETED>SECTION 1. SHORT TITLE.</DELETED>

<DELETED>    This Act may be cited as the ``Adding Zika Virus to the 
FDA Priority Review Voucher Program Act''.</DELETED>

<DELETED>SEC. 2. EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW 
              VOUCHER PROGRAM TO ENCOURAGE TREATMENTS FOR ZIKA 
              VIRUS.</DELETED>

<DELETED>    Section 524(a)(3) of the Federal Food, Drug, and Cosmetic 
Act (21 U.S.C. 360n) is amended--</DELETED>
        <DELETED>    (1) by redesignating subparagraph (R) as 
        subparagraph (S); and</DELETED>
        <DELETED>    (2) by inserting after subparagraph (Q) the 
        following:</DELETED>
                <DELETED>    ``(R) Zika virus.''.</DELETED>

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Adding Zika Virus to the FDA 
Priority Review Voucher Program Act''.

SEC. 2. EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW VOUCHER 
              PROGRAM TO ENCOURAGE TREATMENTS FOR ZIKA VIRUS DISEASE.

    Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 360n(a)(3)) is amended--
            (1) by redesignating subparagraph (R) as subparagraph (S);
            (2) in subparagraph (Q), by striking ``Filoviruses'' and 
        inserting ``Filovirus Diseases''; and
            (3) by inserting after subparagraph (Q) the following:
                    ``(R) Zika Virus Disease.''.
                                                       Calendar No. 389

114th CONGRESS

  2d Session

                                S. 2512

_______________________________________________________________________

                                 A BILL

To expand the tropical disease product priority review voucher program 
                to encourage treatments for Zika virus.

_______________________________________________________________________

                             March 15, 2016

                       Reported with an amendment
